Abstract. For the assessment of the health care system efficiency result-oriented indicators should be exploited much more actively as without specific indicators oriented to the evaluation of the patient's health outcomes it is impossible to acquire reasonable evidence for the effectiveness of the functioning of the health care system that has the decisive role for further decisions in the age of the evidence-based medicine. The main groups of the treatment results' indicators are clinical, economic and patient-reported outcomes (PROs), and all these groups of outcomes should be considered to make the most objective economic evaluation. This research has been determined to investigate applying of PROs as a relatively new tool in evaluation of the health care in Latvia. The results of the scientific publications review show that the positive trend in using of the PROs in Latvia is observed, but the involvement of patients in treatment' process assessment is not enough active yet. The relevant problems and possible suggestions for improvement of this process are discussed in the article.
The economic evaluation of the treatment process is gaining popularity and recognition all over the world due to the introduction of increasingly new technologies in medicine and pharmacy that facilitate achieving inexperienced summits in treating patients; however often simultaneously make the treatment process more expensive. An economic evaluation in health care is defined as "the comparative analysis of alternative courses of action in terms of both their costs and consequences" (Drummond et al., 2000) . The Figure 1 demonstrates the structure of an economic evaluation of the treatment process.
The costs are defined as (Kobelt, 2002 ):
• Direct costs, i.e. costs related to the use of resources due to either the disease or its treatment. They include costs to the health care system, but also to social services and to patients themselves or to their relatives.
• Indirect or productivity costs, i.e. costs related to loss of production, due to either the disease or its treatment, which occur to society.
• Intangible costs, i.e. costs related to suffering and the loss of quality of life due the disease or its treatment, which occurs to the patient. These costs are particularly difficult to measure and value and, as a result, are often left out of any analysis. In determining economic efficiency a significant role belongs to a precise, clear and motivated identification of costs and benefits because the fundamental postulate of cost-effectiveness is based on the assumption that benefits must exceed the costs arising in the process of achieving the benefits. The health care system, however, encounters several problems in establishing cost-effectiveness both regarding the health care system as a whole as well as choosing a specific kind of treatment. One of the main problems is the measurement of the outcomes, because the costs demonstrate the dominated prevalence in monetary value. By reason of the insufficient direct quantitative measures of benefits the qualitative measures are introduced in economic evaluation of the treatment process. The most widely used outcomes' measures are the physiological measures and clinical events, survival, This is an Open Access article distributed under the terms of the Creative Commons Attribution License 2.0, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. quality-adjusted survival, monetary outcome and relatively new group of the measures -the patientreported outcomes.
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The aim of this research
Investigation of the patient-reported outcomes (PROs) as one of the treatment outcome measures for decision-making in health care system of Latvia. In author's opinion this issue becomes topical as due to the introduction of PROs the patient can change the status of a passive subject of treatment to the active participant of treatment.
According to the European Medicines Agency (EMA): "Any outcome based on a patient's perception of a disease and its treatment(s) scored by the patient himself is called a Patient-Reported Outcome (PRO). PROs are a large set of patient-assessed measures ranging from single item (e.g., pain VAS, overall treatment evaluation, and clinical global improvement) to multi-item tools. Multiitem tools can be mono-dimensional (e.g., measuring a single dimension such as physical functioning, fatigue, and sexual function) or multi-dimensional questionnaires measuring several of the following: The disease and treatment process impact the patients' physical, mental and social functioning and the objective of treatment is to improve patients' quality of life. The classical clinical measures are often inadequate to describe and evaluate this effect, and a number of instruments to measure healthrelated quality of life (HRQL) have been developed. Instruments to measure PROs fall into three basic categories that are used in different circumstances and for different purposes (Kielhorn, 
The EuroQol EQ-5D is often use in this way).
Materials and methods
The scientific literature review is used to achieve the aim of the research. Author investigates the scientific publications of the Riga Stradiņš University, as a leader of the university level medical education and research in Latvia, in the time score of 1999-2009. The publications are specified by type of the used PROs questionnaires. Their amount in total number of publications and trends are calculated (Table 1) . But for discussion author proposes to evaluate the structure of these PROs (Figure 3) . (Table 1) show that the applying of PROs rose until 26% in 2006 and decreased in the next years. It could be forecasted that without additional encouraging this indicator will not rise above 20% in future. In author's opinion the main reasons are the following:
Results
-health professionals are not enough informed about advantages of the PROs; -health professionals don't trust the validity and objectivity of the PROs; -not all patients are ready to make their health self-assessment. In 2008 the author carried out the study where the modified EuroQol questionnaire was used for evaluating of the health-related quality of life (HRQL) of the pharmacies' visitors with later involving these data in investigation of the possibilities of using cost-utility analysis of the medication process in Latvia (Arāja, 2010) . Although the used questionnaire is classified as one of the simplest general type HRQL questionnaires it was difficult to complete for the people who have not previously encountered such health self-assessment. 3. It must be considered that in accordance with the new legislative initiative of European Union on pharmacovigilance (Regulation (EU) No 1235/2010 and Directive 2010/84/EU) patients will be allowed to report adverse drug reactions directly to the competent authorities. Additionally, reporting of adverse reactions will be broadened to cover, for example, medication errors and overdose. The new legislation will become applicable in July 2012 [15; 16] . In author's opinion the patient-reported adverse reactions will be the new form of the PROs and question about the readiness of patients in Latvia to make objective assessment of the adverse drug reactions should be under consideration.
4. Taking into account the increasing role of the PROs the crucial point becomes the establishment of the effective and appropriate mechanism for educating of patients in relevant fields. Widely this process should cover the population from the school-age children to retirees, but in the shorter time the main responsibility on educating of patients could be competence of health professionals.
5. Concerning to encouraging the health professionals to use the PROs advantages the question about availability of the Latvian version of the widely used questionnaires is discussible. The questionnaires are available in the Internet and the respective website also provides translated versions in different languages. The largest part of questionnaires is not currently available in Latvian language and it could be one of the possible problems of their applying in Latvia, as the results of this research show very small amount of widely used questionnaires. The researchers choose to use self-prepared questionnaires, but their validity is discussible. For this reason the initiative of the group of researchers (Voicehovska et al., 2010) to study the evaluative and discriminative properties of the Asthma Quality of Life Questionnaire (AQLQ-S) Latvian language version is highly appreciated.
